TRENDS OF INFLUENZA VACCINE DEVELOPMENT
- Authors: Vaslllev Y.1
-
Affiliations:
- Mechnikov Research Institute of Vaccines and Sera
- Issue: Vol 25, No 8 (2014)
- Pages: 12-14
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116005
- ID: 116005
Cite item
Open Access
Access granted
Abstract
Some perspective trends of influenza vaccine development are characterized in the review. Attention is paid to prepandemic and pandemic, virosomal, quadrivalent, cell-culture derived and universal influenza vaccines, as well as adjuvanted and live attenuated influenza vaccines.
Keywords
Full Text
About the authors
Yu. Vaslllev
Mechnikov Research Institute of Vaccines and Sera
Email: yury.m.vasiliev@gmail.com
Candidate of Biological Sciences
References
- Васильев Ю.М. Адъюванты гриппозных вакцин // Журн. микробиол. -2010; 1: 100-10.
- Васильев Ю.М. Вакцины против вируса гриппа птиц // Вопр. вирусол. -2008; 6: 4-15.
- Atsmon J., Kate-Ilovitz E., Shaikevich D. et al. Safety and immunogenicity of multimeric-001-a novel universal influenza vaccine // J. Clin. Immunol. - 2012; 32 (3): 595-603.
- Beyer W., Nauta J., Palache A. et al. Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and metaanalysis // Vaccine. - 2011; 29 (34): 5785-92.
- Beyer W., Palache A., de Jong J. et al. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis // Vaccine. - 2002; 20 (9-10): 1340-53.
- Monto A., Ohmit S., Petrie J. et al. Comparative efficacy of inactivated and live attenuated influenza vaccines // N. Engl. J. Med. - 2009; 361 (13): 1260-7.
- Mutsch M., Zhou W., Rhodes P. et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland // N. Engl. J. Med. -2004; 350 (9): 896-903.
- Shaw M., Palese P. Orthomyxoviridae. In: Knipe D., Howley P. (eds.). Fields Virology / Lippincott Williams & Wilkins, 2013.
- Szymczakiewicz-Multanowska A., Lattanzi M., Izu A. et al. Safety assessment and immunogenicity of a cell-culture-derived influenza vaccine in adults and elderly subjects over three successive influenza seasons // Hum. Vaccin. Immunother. -2012; 8 (5): 645-52.
- Wack A., Baudner B., Hilbert A. et al. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice // Vaccine. - 2008; 26 (4): 552-61.
- WHO. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness // Wkly Epid. Rec. - 2013; 88 (11): 117-25.
- WHO. Recommended composition of influenza virus vaccines for use in the 2013-2014 northern hemisphere influenza season // Wkly Epid. Rec. - 2013; 88 (10): 101-14.
- WHO. Vaccines against influenzaWHO position paper - November 2012 // Wkly Epid. Rec. - 2012; 87 (74): 461-76.
- Wright P., Neumann G., Kawaoka Y. Orthomyxoviruses. In: Knipe D., Howley P. (eds.). Fields Virology / Lippincott Williams & Wilkins, 2013.
- Yin J., Khandaker G., Rashid H. et al. Immunogenicity and safety of pandemic influenza A(H1N1) 2009 vaccine: systematic review and meta-analysis // Influenza Other Respi. Viruses. - 2011; 5 (5): 299-305.
Supplementary files
